Sesen bio, inc. (SESN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue:
Total revenue

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

277

229

65

67

114

244

375

539

761

568

-

622

202

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

425

-

28,650

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

425

-

28,650

277

229

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

8,867

5,420

6,613

7,944

4,686

4,671

3,372

2,779

3,255

3,108

3,619

2,909

2,874

2,795

2,754

3,298

4,632

8,084

6,745

6,269

5,238

5,258

8,872

6,754

5,819

3,212

3,376

2,704

4,496

General and administrative

3,448

3,298

3,238

2,617

3,055

3,495

3,825

2,351

1,952

1,985

1,631

2,241

2,213

2,752

6,366

3,471

2,147

2,319

2,681

2,247

2,603

2,212

2,269

2,052

1,938

1,418

786

881

939

Change in fair value of contingent consideration

-53,700

-

3,600

44,000

-1,000

-

7,200

3,900

-1,200

-

3,900

2,200

1,500

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-41,385

33,738

13,451

54,561

6,741

7,066

14,397

9,030

4,007

6,593

9,150

7,350

6,587

4,447

9,120

6,769

6,779

10,403

9,426

8,516

7,841

7,470

11,141

8,806

7,757

4,630

4,162

3,585

5,435

Income (Loss) from Operations

41,385

-33,738

-13,451

-54,561

-6,741

-7,066

-14,397

-9,030

-4,007

-6,593

-9,150

-7,350

-6,162

-3,622

19,530

-6,492

-6,550

-9,838

-9,359

-8,402

-7,597

-7,095

-10,602

-8,045

-7,189

-4,120

-3,540

-3,383

-5,435

Other income (expense):
Other income, net

179

185

319

226

261

309

382

72

44

46

45

34

101

-819

-43

1

138

-68

73

1,826

1,308

-905

2

3

51

-51

16

-114

2

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-915

-

0

0

0

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-247

-423

-407

-330

-235

-139

-74

-79

-84

-895

-289

-137

-79

Total other income, net

-

-

-

226

-

-

-

72

44

-

45

34

101

96

-43

1

-1,024

-491

-334

1,496

1,073

-1,044

-72

-76

-33

-946

-273

-251

-77

Net Income (Loss) and Comprehensive Income (Loss)

41,564

-33,553

-13,132

-54,335

-6,480

-6,757

-14,015

-8,958

-3,963

-6,547

-9,105

-7,316

-6,061

-3,531

19,487

-6,491

-7,574

-10,329

-9,693

-6,906

-6,524

-8,139

-10,674

-8,121

-7,222

-5,066

-3,813

-3,634

-5,512

Cumulative preferred stock dividends and accretion of preferred stock discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

519

1,142

905

917

893

Net income (loss) attributable to common stockholders - basic

34,407

-

-

-

-6,480

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,139

-10,674

-8,121

-7,741

-6,208

-4,718

-4,551

-6,405

Net Income (Loss) Available to Common Stockholders, Diluted

34,408

-

-

-

-6,480

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share - basic (in dollars per share)

0.31

-

-

-

-0.08

-

-

-

-

-

-

-

-

-

0.95

-

-

-

-0.50

-

-

-

-

-

-

-

-

-

-

Weighted-average common shares outstanding - basic (in shares)

109,808

-

-

-

77,458

-

-

-

-

-

-

-

-

-

20,495

-

-

-

19,345

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share - diluted (in dollars per share)

0.31

-

-

-

-0.08

-

-

-

-

-

-

-

-

-

0.91

-

-

-

-0.50

-

-

-

-

-

-

-

-

-

-

Weighted-average common shares outstanding - diluted (in shares)

109,823

-

-

-

77,458

-

-

-

-

-

-

-

-

-

21,423

-

-

-

19,345

-

-

-

-

-

-

-

-

-

-

Net loss per common share - basic and diluted (in dollars per share)

-

-0.32

-0.13

-0.67

-

-0.10

-0.18

-0.16

-0.11

-0.19

-0.37

-0.30

-0.25

-

-

-0.33

-0.39

-

-

-0.36

-0.36

-

-0.66

-510.00

-0.80

-4.21

-3.39

-3.44

-5.14

Weighted-average common shares outstanding - basic and diluted (in shares)

-

-

101,266

80,739

-

77,971

77,030

56,421

35,674

30,434

24,691

24,685

24,610

-

-

19,874

19,639

-

-

19,087

17,971

-

16,098

16,055

9,635

1,449

1,390

1,322

1,247